Skip to main content
SpringerLink
Log in

Diagnose, Therapie und Verlaufskontrolle der diabetischen Augenerkrankung

  • Gesellschaftliches
  • Praxis-Richtlinien der Österreichischen Diabetesgesellschaft (Update Juni 2006)
  • Published:
Spektrum der Augenheilkunde Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Screening guidelines for diabetic retinopathy (1992) American College of Physicians, American Diabetes Association, and American Academy of Ophthalmology. Ann Intern Med 116 (8): 683–5

    Google Scholar 

  2. Khadem J, Buzney S, Alich K (1999) Practice patterns in diabetic retinopathy: part 1: analysis of retinopathy follow-up. Arch Ophthalmol 117 (6): 815–20

    PubMed  CAS  Google Scholar 

  3. McCarty C, et al (2001) Diabetic retinopathy: effects of national guidelines on the referral, examination and treatment practices of ophthalmologists and optometrists. Clin Exp Ophthalmol 29 (2): 52–8

    Article  CAS  Google Scholar 

  4. Wilkinson C, et al (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110 (9): 1677–82

    Article  PubMed  CAS  Google Scholar 

  5. Hammes H, Lemmen K (2002) Diagnostik, Therapie und Verlaufskontrolle der diabetischen Retinopathie und Makulopathie. Diabetes und Stoffwechsel 11 [Suppl 2]: 15–16

    Google Scholar 

  6. Klein R, et al (1984) The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol102 (4): 527–32

    PubMed  CAS  Google Scholar 

  7. Klein R, et al (1984) The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology 91 (12): 1464–74

    PubMed  CAS  Google Scholar 

  8. Klein R, et al (1984) The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102 (4): 520–6.

    PubMed  CAS  Google Scholar 

  9. Klein R, Klein BE, Moss SE (1992) Epidemiology of proliferative diabetic retinopathy. Diabetes Care 15 (12): 1875–91

    Article  PubMed  CAS  Google Scholar 

  10. Moss SE, Klein R, Klein BE (1988) The incidence of vision loss in a diabetic population. Ophthalmology 95 (10): 1340–8

    PubMed  CAS  Google Scholar 

  11. Zhang L, et al (2001) Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care 24 (7): 1275–9

    Article  PubMed  CAS  Google Scholar 

  12. Stratton I, et al (2001) UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 44 (2): 156–63

    Article  PubMed  CAS  Google Scholar 

  13. Murphy RP, et al (1990) The relationship of puberty to diabetic retinopathy. Arch Ophthalmol 108 (2): 215–8

    PubMed  CAS  Google Scholar 

  14. The Diabetes Control and Complications Trial Research Group (2000) Effect of pregnancy on microvascular complications in the diabetes control and complications trial. Diabetes Care 23 (8): 1084–91

    Article  Google Scholar 

  15. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial (1998) Arch Ophthalmol 116 (7): 874–86

    Google Scholar 

  16. Orchard T, et al (2001) Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 24 (6): 1053–9

    Article  PubMed  CAS  Google Scholar 

  17. Sen K, et al (2002) Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia. Diabetes Res Clin Pract 56 (1): 1–11

    Article  PubMed  CAS  Google Scholar 

  18. The absence of a glycemic threshold for the development of longterm complications: the perspective of the Diabetes Control and Complications Trial (1996) Diabetes 45(10): 1289–98

    Article  Google Scholar 

  19. Klein R, et al (1995) The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 102 (1): 7–16

    PubMed  CAS  Google Scholar 

  20. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317 (7160): 703–13

    Google Scholar 

  21. Nasr C, et al (1999) United Kingdom Prospective Diabetes Study (UKPDS). Effects of glucose and blood pressure control on complications of type 2 diabetes mellitus. Cleve Clin J Med 66 (4): 247–53

    PubMed  CAS  Google Scholar 

  22. Berman D, Friedman E (1994) Partial absorption of hard exudates in patients with diabetic end-stage renal disease and severe anemia after treatment with erythropoietin. Retina 14 (1): 1–5

    PubMed  CAS  Google Scholar 

  23. Friedman E, Brown C, Berman D (1995) Erythropoietin in diabetic macular edema and renal insufficiency. Am J Kidney Dis 26 (1): 202–8

    Article  PubMed  CAS  Google Scholar 

  24. Davis M, et al (1998) Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci 39 (2): 233–52

    PubMed  CAS  Google Scholar 

  25. The Early Treatment Diabetic Retinopathy Study Research Group (1987) Case reports to accompany Early Treatment Diabetic Retinopathy Study Reports 3 and 4. Int Ophthalmol Clin 27 (4): 273–333

    Article  Google Scholar 

  26. Early Treatment Diabetic Retinopathy Study Research Group (1991) Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 5 (1): 823–33

    Google Scholar 

  27. Kassoff A, Catalano R, Mehu M (1988) Vitreous hemorrhage and the Valsalva maneuver in proliferative diabetic retinopathy. Retina 8 (3): 174–6

    Article  PubMed  CAS  Google Scholar 

  28. Lindgren G, Lindblam B (1996) Causes of vitreous hemorrhage. Curr Opin Ophthalmol 7 (3): 13–9

    Article  PubMed  CAS  Google Scholar 

  29. Fong D, et al (1999) Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. Am J Ophthalmol 127 (2): 137–41

    Article  PubMed  CAS  Google Scholar 

  30. Lindgren G, Sjodell L, Lindblom B (1995) A prospective study of dense spontaneous vitreous hemorrhage. Am J Ophthalmol 119 (4): 458–65

    PubMed  CAS  Google Scholar 

  31. Basteau F, et al (1999) Vitreous hemorrhage and pre-retinal hemorrhage „without obvious point of origin“ in diabetic patients. Apropos of 5 cases. J Fr Ophtalmol 22 (5): 528–35

    PubMed  CAS  Google Scholar 

  32. Scott I, Flynn H, Hughes J (2001) Echographic evaluation of a patient with diabetes and dense vitreous hemorrhage: an avulsed retinal vessel may mimic a tractional retinal detachment. Am J Ophthalmol 131 (4): 515–6

    Article  PubMed  CAS  Google Scholar 

  33. Flynn HJ, et al (1992) Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study. ETDRS report number 17. The Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 99 (9): 1351–7

    PubMed  Google Scholar 

  34. Hamard P, Baudouin C (2000) Consensus on neovascular glaucoma. J Fr Ophtalmol 23 (3): 289–94

    PubMed  CAS  Google Scholar 

  35. Hamanaka T, et al (2001) Retinal ischemia and angle neovascularization in proliferative diabetic retinopathy. Am J Ophthalmol 132 (5): 648–58

    Article  PubMed  CAS  Google Scholar 

  36. Smith RT, et al (1987) Quantification of diabetic macular edema. Arch Ophthalmol 105 (2): 218–22

    PubMed  CAS  Google Scholar 

  37. Antcliff R, Marshall J (1999) The pathogenesis of edema in diabetic maculopathy. Semin Ophthalmol 14 (4): 223–32

    Article  PubMed  CAS  Google Scholar 

  38. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes (2002) JAMA 287 (19): 2542–51

    Article  Google Scholar 

  39. Gray A, et al (2001) An economic evaluation of atenolol vs. captopril in patients with Type 2 diabetes (UKPDS 54). Diabet Med 18 (6): 438–44

    Article  PubMed  CAS  Google Scholar 

  40. Davis T, Cull C, Holman R (2001) Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55). Diabetes Care 24 (7): 1167–74

    Article  PubMed  CAS  Google Scholar 

  41. Early Treatment Diabetic Retinopathy Study Research Group (1987) Treatment techniques and clinical guidelines for photocoagulation of diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 2. Ophthalmology 94 (7): 761–74

    Google Scholar 

  42. Kinyoun J, et al (1989) Detection of diabetic macular edema. Ophthalmoscopy versus photography — Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group. Ophthalmology 96 (6): 746–50; discussion 750–1

    PubMed  CAS  Google Scholar 

  43. Kinyoun J, et al (1989) Detection of diabetic macular edema. Ophthalmoscopy versus photography — Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group. Ophthalmology 96 (6): 746–50

    PubMed  CAS  Google Scholar 

  44. Gonzalez Villalpando C, et al (1997) A diabetic retinopathy screening program as a strategy for blindness prevention. Arch Med Res 28 (1): 129–35

    Google Scholar 

  45. Teich SA, JB Walsh (1981) A grading system for iris neovascularization. Prognostic implications for treatment. Ophthalmology 88 (11): 1102–6

    PubMed  CAS  Google Scholar 

  46. Pandit RJ, Taylor R (2002) Quality assurance in screening for sight-threatening diabetic retinopathy. Diabet Med 19 (4): 285–91

    Article  PubMed  CAS  Google Scholar 

  47. Kuo HK, Hsieh HH, Liu RT (2005) Screening for diabetic retinopathy by one-field, non-mydriatic, 45 degrees digital photography is inadequate. Ophthalmologica 219 (5): 292–6

    Article  PubMed  Google Scholar 

  48. Leese GP, et al (2002) Does direct ophthalmoscopy improve retinal screening for diabetic eye disease by retinal photography? Diabet Med 19 (10): 867–9

    Article  PubMed  CAS  Google Scholar 

  49. Rudnisky C, et al (2002) High-resolution stereoscopic digital fundus photography versus contact lens biomicroscopy for the detection of clinically significant macular edema. Ophthalmology 109 (2): 267–74

    Article  PubMed  Google Scholar 

  50. Herbert HM, Jordan K, Flanagan DW (2003) Is screening with digital imaging using one retinal view adequate? Eye 17 (4): 497–500

    Article  PubMed  CAS  Google Scholar 

  51. Early Treatment Diabetic Retinopathy Study Research Group (1991) Fluorescein angiographic risk factors for progression of diabetic retinopathy. ETDRS report number 13. Ophthalmology 98 [5 Suppl]: 834–40

    Google Scholar 

  52. Shimizu K, Kobayashi Y, Muraoka K (1981) Midperipheral fundus involvement in diabetic retinopathy. Ophthalmology 88 (7): 601–12

    PubMed  CAS  Google Scholar 

  53. Early Treatment Diabetic Retinopathy Study Research Group (1991) Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Ophthalmology 98 [5 Suppl]: 807–22

    Google Scholar 

  54. Hee M, et al (1998) Topography of diabetic macular edema with optical coherence tomography. Ophthalmology 105 (2): 360–70

    Article  PubMed  CAS  Google Scholar 

  55. Gallemore R, et al (2000) Diagnosis of vitreoretinal adhesions in macular disease with optical coherence tomography. Retina 20 (2): 115–20

    Article  PubMed  CAS  Google Scholar 

  56. Giovannini A, et al (2000) Optical coherence tomography findings in diabetic macular edema before and after vitrectomy. Ophthalmic Surg Lasers 31 (3): 187–91

    PubMed  CAS  Google Scholar 

  57. Kohner E, et al (2001) Relationship between the severity of retinopathy and progression to photocoagulation in patients with Type 2 diabetes mellitus in the UKPDS (UKPDS 52). Diabet Med 18 (3): 178–84

    Article  PubMed  CAS  Google Scholar 

  58. The Diabetes Control and Complications Trial (1995) The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol 113 (1): 36–51

    Google Scholar 

  59. Squirrell D, et al (2002) A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol 86 (5): 565–71

    Article  PubMed  CAS  Google Scholar 

  60. Flesner P, et al (2002) Cataract surgery on diabetic patients. A prospective evaluation of risk factors and complications. Acta Ophthalmol Scand 80 (1): 19–24

    Article  PubMed  Google Scholar 

  61. Chung J, et al (2002) Effect of cataract surgery on the progression of diabetic retinopathy. J Cataract Refract Surg 28 (4): 626–30

    Article  PubMed  Google Scholar 

  62. Gupta A, Gupta V (2001) Diabetic maculopathy and cataract surgery. Ophthalmol Clin North Am 14 (4): 625–37

    Article  PubMed  CAS  Google Scholar 

  63. Raskauskas PA, et al (1999) Small incision cataract surgery and placement of posterior chamber intraocular lenses in patients with diabetic retinopathy. Ophthalmic Surg Lasers 30 (1): 6–11

    PubMed  CAS  Google Scholar 

  64. Kato S, et al (1999) Influence of phacoemulsification and intraocular lens implantation on the course of diabetic retinopathy. J Cataract Refract Surg 25 (6): 788–93

    Article  PubMed  CAS  Google Scholar 

  65. Cunha-Vaz J (1998) Lowering the risk of visual impairment and blindness. Diabet Med 15 [Suppl 4]: 47–50

    Article  Google Scholar 

  66. Bailey C, et al (1999) The National Diabetic Retinopathy Laser Treatment Audit. III. Clinical outcomes. Eye 13 (Pt 2): 151–9

    PubMed  Google Scholar 

  67. Early Treatment Diabetic Retinopathy Study research group (1985) Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 103 (12): 1796–806

    Google Scholar 

  68. Early Treatment Diabetic Retinopathy Study Research Group (1995) Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Arch Ophthalmol 113 (9): 1144–55

    Google Scholar 

  69. Gupta A, et al (1996) Risk factors influencing the treatment outcome in diabetic macular oedema. Indian J Ophthalmol 44 (3): 145–8

    PubMed  CAS  Google Scholar 

  70. The Diabetic Retinopathy Study Research Group (1976) Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol 81 (4): 383–96

    Google Scholar 

  71. The Early Treatment Diabetic Retinopathy Study Research Group (1987) Techniques for scatter and local photocoagulation treatment of diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report no. 3. Int Ophthalmol Clin 27 (4): 254–64

    Article  Google Scholar 

  72. Ferris F (1996) Early photocoagulation in patients with either type I or type II diabetes. Trans Am Ophthalmol Soc 94: 505–37

    PubMed  CAS  Google Scholar 

  73. Bodanowitz S, et al (1996) Vitrectomy in diabetic patients with a blind fellow eye. Acta Ophthalmol Scand 74 (1): 84–8

    Article  PubMed  CAS  Google Scholar 

  74. Early Treatment Diabetic Retinopathy Study Research Group (1991) Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology 98 [5 Suppl]: 766–85

    Google Scholar 

  75. The Diabetic Retinopathy Vitrectomy Study Research Group (1990) Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: Diabetic Retinopathy Study Report 5. Arch Ophthalmol 108 (7): 958–64

    Google Scholar 

  76. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial — Diabetic Retinopathy Vitrectomy Study Report 4. Ophthalmology 95(10): 1321–34

  77. Yamamoto T, et al (2003) Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema. Am J Ophthalmol 135 (1): 14–9

    Article  PubMed  Google Scholar 

  78. Massin P, et al (2003) Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy. Am J Ophthalmol 135 (2): 169–77

    Article  PubMed  Google Scholar 

  79. Klein BE, Klein R, Moss SE (1995) Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 119 (3): 295–300

    PubMed  CAS  Google Scholar 

  80. Henricsson M, Heijl A., Janzon L (1996) Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol 80 (9): 789–93

    Article  PubMed  CAS  Google Scholar 

  81. Nakai A, et al (1994) Bilateral ptosis with ophthalmoplegia in a 72-year-old woman with diabetes. Diabetes Res 26 (2): 89–92

    PubMed  CAS  Google Scholar 

  82. Larkin G, Elston J, Bain P (1990) Disorders of ocular motility. Br J Hosp Med 44 (4): 271–5

    PubMed  CAS  Google Scholar 

  83. Rand LI, et al (1985) Factors influencing the development of visual loss in advanced diabetic retinopathy. Diabetic Retinopathy Study (DRS) Report No. 10. Invest Ophthalmol Vis Sci 26 (7): 983–91

    PubMed  CAS  Google Scholar 

  84. Kohner EM, Barry PJ (1984) Prevention of blindness in diabetic retinopathy. Diabetologia 26 (3): 173–9

    Article  PubMed  CAS  Google Scholar 

  85. Kaufman SC, et al (1989) Factors associated with visual outcome after photocoagulation for diabetic retinopathy. Diabetic Retinopathy Study Report 13. Invest Ophthalmol Vis Sci 30 (1): 23–8

    PubMed  CAS  Google Scholar 

  86. Doft BH, Metz DJ, Kelsey SF (1992) Augmentation laser for proliferative diabetic retinopathy that fails to respond to initial panretinal photocoagulation. Ophthalmology 99 (11): 1728–34

    PubMed  CAS  Google Scholar 

  87. Dogru M, et al (1999) Long-term visual outcome in proliferative diabetic retinopathy patients after panretinal photocoagulation. Jpn J Ophthalmol 43 (3): 217–24

    Article  PubMed  CAS  Google Scholar 

  88. Schatz H, et al (1991) Progressive enlargement of laser scars following grid laser photocoagulation for diffuse diabetic macular edema. Arch Ophthalmol 109 (11): 1549–51

    PubMed  CAS  Google Scholar 

  89. Browning D, et al (1997) The effect of patient characteristics on response to focal laser treatment for diabetic macular edema. Ophthalmology 104 (3): 466–72

    PubMed  CAS  Google Scholar 

  90. Jonas J, Sofker A (2001) Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132 (3): 425–7

    Article  PubMed  CAS  Google Scholar 

  91. Martidis A, et al (2002) Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109 (5): 920–7

    Article  PubMed  Google Scholar 

  92. Manzano RP, et al (2006) Testing intravitreal toxicity of bevacizumab (Avastin). Retina 26 (3): 257–61

    Article  PubMed  Google Scholar 

  93. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative agerelated macular degeneration (2002) Retina 22 (2): 143–52

    Article  Google Scholar 

  94. Funatsu H, et al (2002) Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema. Am J Ophthalmol 133 (1): 70–7

    Article  PubMed  CAS  Google Scholar 

  95. Funatsu H, et al (2003) Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema. Ophthalmology 110 (9): 1690–6

    Article  PubMed  Google Scholar 

  96. Adamis AP, et al (2006) Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 113 (1): 23–8

    Article  PubMed  Google Scholar 

  97. Cunningham ET, Jr et al (2005) A phase II randomized doublemasked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema. Ophthalmology 112 (10): 1747–57

    Article  PubMed  Google Scholar 

  98. Gaudreault J, et al (2005) Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration. Invest Ophthalmol Vis Sci 46 (2): 726–33

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitätsklinik für Augenheilkunde und Optometrie, Medizinische Universität Wien, Österreich

    M. Stur

  2. Landesaugenklinik Salzburg, Österreich

    S. Egger

  3. Universitätsklinik für Augenheilkunde und Optometrie, Medizinische Universität Graz, Österreich

    A. Haas

  4. Universitätsklinik für Augenheilkunde und Optometrie, Medizinische Universität Innsbruck, Österreich

    G. Kieselbach

  5. Augenabteilung, Landeskrankenhaus Feldkirch, Österreich

    S. Mennel

  6. Augenabteilung, Hanusch-Krankenhaus, Wien, Österreich

    R. Michl

  7. Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Österreich

    M. Roden

  8. Augenabteilung, Krankenanstalt Rudolfstiftung, Ludwig-Boltzmann-Institut für Retinologie und Biomikroskopische Laserchirurgie, Wien, Österreich

    U. Stolba

  9. Anton-Frank-Gasse 5, 1180, Wien, Österreich

    A. Wedrich

Authors
  1. M. Stur
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Egger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Haas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. G. Kieselbach
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Mennel
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Michl
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Roden
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. U. Stolba
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. A. Wedrich
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. Stur.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stur, M., Egger, S., Haas, A. et al. Diagnose, Therapie und Verlaufskontrolle der diabetischen Augenerkrankung. Spektrum Augeheilkd 20, 234–240 (2006). https://doi.org/10.1007/BF03163807

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03163807

Search

Navigation